Literature DB >> 10846100

The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells.

H A Pancio1, N Vander Heyden, L Ratner.   

Abstract

Human immunodeficiency virus type 2 (HIV-2), like other lentiviruses, is capable of infecting nondividing T cells and macrophages. The present work shows that in HIV-2-infected cells, Vpx is necessary for efficient nuclear import of the preintegration complex. In agreement with this finding, the subcellular localization of a GFP-Vpx fusion protein was found to be predominantly nuclear. However, deletion of the proline-rich C-terminal 11 residues of Vpx resulted in a shift of the fusion protein to the cytoplasm. Furthermore, the same deletion in the context of the provirus resulted in a decrease in nuclear import of the preintegration complex and attenuated replication in macrophages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846100      PMCID: PMC112115          DOI: 10.1128/jvi.74.13.6162-6167.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells.

Authors:  P J Mosca; P A Dijkwel; J L Hamlin
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  Analysis of the function of viral protein X (VPX) of HIV-2.

Authors:  W Hu; N Vander Heyden; L Ratner
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

3.  The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex.

Authors:  A Radu; M S Moore; G Blobel
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

4.  A karyophilic protein forms a stable complex with cytoplasmic components prior to nuclear pore binding.

Authors:  N Imamoto; T Tachibana; M Matsubae; Y Yoneda
Journal:  J Biol Chem       Date:  1995-04-14       Impact factor: 5.157

5.  HIV-2 viral protein X association with the GAG p27 capsid protein.

Authors:  R Horton; P Spearman; L Ratner
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

6.  Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus.

Authors:  P F Lewis; M Emerman
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions.

Authors:  Y L Lu; P Spearman; L Ratner
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  The GTP-binding protein Ran/TC4 is required for protein import into the nucleus.

Authors:  M S Moore; G Blobel
Journal:  Nature       Date:  1993-10-14       Impact factor: 49.962

9.  Evolution of the primate lentiviruses: evidence from vpx and vpr.

Authors:  M Tristem; C Marshall; A Karpas; F Hill
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

10.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

View more
  34 in total

1.  Interaction of human immunodeficiency virus type 2 Vpx and invariant chain.

Authors:  H A Pancio; N Vander Heyden; K Kosuri; P Cresswell; L Ratner
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Differential regulatory activities of viral protein X for anti-viral efficacy of nucleos(t)ide reverse transcriptase inhibitors in monocyte-derived macrophages and activated CD4(+) T cells.

Authors:  Joseph A Hollenbaugh; Susan M Schader; Raymond F Schinazi; Baek Kim
Journal:  Virology       Date:  2015-08-29       Impact factor: 3.616

3.  Simian immunodeficiency virus Vpx is imported into the nucleus via importin alpha-dependent and -independent pathways.

Authors:  Prabhat K Singhal; P Rajendra Kumar; Malireddi R K Subba Rao; Mahesh Kyasani; Sundarasamy Mahalingam
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Hsp40 facilitates nuclear import of the human immunodeficiency virus type 2 Vpx-mediated preintegration complex.

Authors:  Xiaogang Cheng; Michael Belshan; Lee Ratner
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 5.  Viral proteins and Src family kinases: Mechanisms of pathogenicity from a "liaison dangereuse".

Authors:  Mario Angelo Pagano; Elena Tibaldi; Giorgio Palù; Anna Maria Brunati
Journal:  World J Virol       Date:  2013-05-12

6.  Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages.

Authors:  Mikako Fujita; Masami Otsuka; Masami Miyoshi; Boonruang Khamsri; Masako Nomaguchi; Akio Adachi
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

Review 7.  The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.

Authors:  Laurieann Casey; Xiaoyun Wen; Carlos M C de Noronha
Journal:  Cytokine       Date:  2010-03-27       Impact factor: 3.861

8.  Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes.

Authors:  André Berger; Carsten Münk; Matthias Schweizer; Klaus Cichutek; Silke Schüle; Egbert Flory
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

9.  Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells.

Authors:  Caroline Goujon; Vanessa Arfi; Thomas Pertel; Jeremy Luban; Julia Lienard; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

10.  Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj.

Authors:  Silke Schüle; Björn-Philipp Kloke; Julia K Kaiser; Sabine Heidmeier; Sylvia Panitz; Nina Wolfrum; Klaus Cichutek; Matthias Schweizer
Journal:  PLoS One       Date:  2009-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.